Oncotarget publishes phase 1 study of Z-Endoxifen in patients with advanced cancers

[News]

Oncotarget published "Phase 1 study of Z-Endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors" which reported that Z-endoxifen administration was anticipated to bypass these variations, increasing active drug levels, and potentially benefiting patients responding sub-optimally to tamoxifen.

More... (https://www.news-medical.net/news/20210325/Oncotarget-publishes-Phase-1-study-of-Z-Endoxifen-in-patients-with-advanced-cancers.aspx)